Is intravenous iron really useful in inflammatory bowel disease? Would oral iron not be simpler and cheaper?;¿Realmente sirve para algo el hierro intravenoso en el tratamiento de la enfermedad inflamatoria intestinal? ¿No es más sencillo y más barato el hierro oral?

Gastroenterologia y Hepatologia

Volumn 32, Issue 1, 2009, Pages 63-64

  Bermejo San José, Fernando ^a  

^a HOSPITAL UNIVERSITARIO DE FUENLABRADA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN; IRON;

ARTICLE; DRUG ABSORPTION; DRUG COST; DRUG EFFICACY; DRUG TOLERANCE; ENTERITIS; HEMOGLOBIN BLOOD LEVEL; HUMAN; INTESTINE MUCOSA;

EID: 63149137656     PISSN: 02105705     EISSN: 15789519     Source Type: Journal    
DOI: 10.1016/j.gastrohep.2008.09.003     Document Type: Article

References (16)

1. Gasche C., Lomer M.C., Cavill I., and Weiss G. Iron, anaemia, and inflammatory bowel diseases. Gut 53 (2004) 1190-1197
2. Kulnigg S., and Gasche C. Systematic review: managing anaemia in Crohn's disease. Aliment Pharmacol Ther 24 (2006) 1507-1523
3. Kawai M., Sumimoto S., Kasajima Y., and Hamamoto T. A case of ulcerative colitis induced by oral ferrous sulfate. Acta Paediatr Jpn 34 (1992) 476-478
4. De Silva A.D., Mylonaki M., and Rampton D.S. Oral iron therapy in inflammatory bowel disease: usage, tolerance, and efficacy. Inflamm Bowel Dis 9 (2003) 316-320
5. Erichsen K., Ulvik R.J., Nysaeter G., Johansen J., Ostborg J., Berstad A., et al. Oral ferrous fumarate or intravenous iron sucrose for patients with inflammatory bowel disease. Scand J Gastroenterol 40 (2005) 1058-1065
6. De Silva A.D., Tsironi E., Feakins R.M., and Rampton D.S. Efficacy and tolerability of oral iron therapy in inflammatory bowel disease: a prospective, comparative trial. Aliment Pharmacol Ther 22 (2005) 1097-1105
7. Gasche C., Berstad A., Befrits R., Beglinger C., Dignass A., Erichsen K., et al. Guidelines on the diagnosis and management of iron deficiency and anemia in inflammatory bowel disease. Inflamm Bowel Disease 13 (2007) 1545-1553
8. De la Morena F., and Gisbert J.P. Anemia y enfermedad inflamatoria intestinal. Rev Esp Enferm Dig 100 (2008) 285-293
9. Schroder O., Mickisch O., Seidler U., De Weerth A., Dignass A.U., Herfarth H., et al. Intravenous iron sucrose versus oral iron supplementation for the treatment of iron deficiency anemia in patients with inflammatory bowel disease -a randomized, controlled, open-label, multicenter study. Am J Gastroenterol 100 (2005) 2503-2509
10. Erichsen K., Hausken T., Ulvik R.J., Svardal A., Berstad A., and Berge R.K. Ferrous fumarate deteriorated plasma antioxidant status in patients with Crohn disease. Scand J Gastroenterol 38 (2003) 543-548
11. Erichsen K., Ulvik R.J., Grimstad T., Berstad A., Berge R.K., and Hausken T. Effects of ferrous sulphate and non-ionic iron-polymaltose complex on markers of oxidative tissue damage in patients with inflammatory bowel disease. Aliment Pharmacol Ther 22 (2005) 831-838
12. Oldenburg B., Koningsberger J.C., Van Berge Henegouwen G.P., Van Asbeck B.S., and Marx J.J. Iron and inflammatory bowel disease. Aliment Pharmacol Ther 15 (2001) 429-438
13. Gisbert J.P., and Gomollón F. Common misconceptions in the diagnosis and management of anemia in with inflammatory bowel disease. Am J Gastroenterol 103 (2008) 1299-1307
14. Bodemar G., Kechagias S., Almer S., and Danielson B.G. Treatment of anaemia in inflammatory bowel disease with iron sucrose. Scand J Gastroenterol 39 (2004) 454-458
15. a ed. Barcelona: Ediciones Doyma SCM; 2006; 465-76.
16. Kulnigg S., Stionov S., Simanenkov V., Dudar L.V., Karnafel W., García L.C., et al. A novel intravenous iron formulation for treatment of anemia in inflammatory bowel disease: the ferric carboxymaltose (FERINJECT) randomized controlled trial. Am J Gastroenterol 103 (2008) 1182-1192